Triangle Healthcare Advisors
Triangle Healthcare Advisors, LLC states that it specializes exclusively in healthcare services and is particularly active in home infusion and ambulatory infusion center transactions. Its described sell-side process includes confidential marketing, valuation preparation, buyer identification, competitive bidding, diligence management, LOI negotiation, and post-closing support.
What stands out about Triangle Healthcare Advisors
Triangle Healthcare Advisors publicly presents a healthcare-focused M&A advisory and registered business-broker model, with services spanning sell-side preparation and execution, valuation, private-equity transactions, joint ventures, partnerships, appraisal, and transition planning. Owners should confirm engagement economics, comparable transaction experience, conflicts, assigned personnel, valuation methodology, and regulatory status directly.[1][2][3][6]
What does Triangle Healthcare Advisors do?
Triangle Healthcare Advisors, LLC describes itself as a registered business broker and M&A advisory firm specializing exclusively in healthcare services. The firm states that it has advised on the purchase and sale of hundreds of healthcare companies and on approximately $500 million of infusion-company sale transactions since 2021.[1]
Publicly stated services include M&A advisory, transition planning, private-equity transactions, joint ventures, partnerships, appraisal, and valuation services. The firm’s sell-side process includes financial and KPI review, preliminary valuation, preparation of a confidential investment memorandum and blind teaser, buyer identification, data-room organization, confidentiality management, bid-process and letter-of-intent negotiation, diligence management, and post-closing support.[1][2]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring Triangle Healthcare Advisors?
Owners considering Triangle should ask which legal entity would sign the engagement letter and which business-broker or other licenses and registrations apply to the proposed services. The engagement should also be evaluated against the proposed success fee, minimum fee, retainer, tail, expense reimbursement, termination, and exclusivity provisions, because the official services page does not publish standard terms.
Owners may also wish to request comparable transactions by service line, payer mix, EBITDA, geography, and ownership structure; clarify how strategic, private-equity, and add-on buyers are screened and contacted; identify the day-to-day transaction lead; and understand how conflicts are handled when Triangle has buyer-side or other relationships. Valuation methodology, quality-of-earnings expectations, earnout or holdback guidance, and the scope of post-closing support should be confirmed directly.[2][3]
Which recent transactions can Triangle discuss by service line, payer mix, EBITDA, geography, and ownership structure
What legal entity would sign the engagement letter, and what business-broker or other licenses and registrations apply to the proposed services
What are the success fee, minimum fee, retainer, tail, expense reimbursement, termination, and exclusivity provisions
What size transactions and clients does Triangle Healthcare Advisors focus on?
Triangle states that it is particularly active in home infusion and ambulatory infusion center transactions. It also identifies pharmacies, hospice, home health, urgent care, home medical equipment, respiratory therapy, physician practices, and ancillary healthcare services as areas in which it works.[1]
Triangle’s News & Insights page identifies its advice on Pinnacle Revenue Management’s sale to Acu-Serve; TANYR’s sale to Acu-Serve; IV Care Options and MD Health Solutions’ sale to Palmetto Infusion; and Intramed Plus’s sale to Option Care Health.
The official transactions page states that Triangle has advised on 17 infusion-related deals worth over $500 million since 2021 and has an additional $250 million or more in active mandates.[3][4]
The firm publicly describes experience with sell-side M&A, private-equity transactions, joint ventures, and partnerships, as well as appraisal and valuation work. Its stated process emphasizes confidential marketing, buyer-list development, competitive bidding, letters of intent, diligence management, and transaction execution.[1][2]
What does Triangle Healthcare Advisors publicly disclose about fees, process and engagement terms?
The official services page does not publish a universal success-fee percentage, minimum fee, tail period, termination schedule, or standard engagement-fee terms.
The official services page does not publish a universal minimum revenue, EBITDA, valuation, employee-count, or transaction-size threshold for accepting an engagement.
The official transactions page does not disclose transaction consideration, valuation multiples, financing terms, seller-retention terms, or complete buyer and seller identities for its image-based transaction display.[2][3]
Triangle’s website describes Triangle Healthcare Advisors, LLC as a registered business broker. A Florida Department of State record lists TRIANGLE HEALTHCARE ADVISORS, LLC as an active Florida limited liability company filed April 8, 2025, with Robert Monahan, Benjamin Monahan, and Joseph Monahan listed as authorized members.
The reviewed Florida Department of State entity record establishes the active LLC and authorized members but does not establish SEC, FINRA, or state securities-registration status for Triangle Healthcare Advisors. The firm’s exact regulatory status should be confirmed directly for the contemplated engagement.[1][6]
Triangle describes a sell-side process involving financial and KPI review, preliminary valuation, confidential investment memorandum and blind-teaser preparation, buyer identification, data-room organization, confidentiality management, competitive bidding, letter-of-intent negotiation, diligence management, and transaction execution. The firm also states that it provides post-closing support.[2]
Questions to ask before hiring Triangle Healthcare Advisors
Which recent transactions can Triangle discuss by service line, payer mix, EBITDA, geography, and ownership structure?
What legal entity would sign the engagement letter, and what business-broker or other licenses and registrations apply to the proposed services?
What are the success fee, minimum fee, retainer, tail, expense reimbursement, termination, and exclusivity provisions?
How are strategic buyers, private-equity buyers, and add-on buyers screened and contacted?
Who will lead the process day to day, and how are conflicts handled when Triangle has buyer-side or other relationships?
What valuation methodology, quality-of-earnings expectations, earnout or holdback guidance, and post-closing support are included?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Geography / market coverage
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.